These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1237082)

  • 21. 3-hydroxymethyl-7-(N-substituted aminosulfonyl)-1,2,3,4-tetrahydroisoquinoline inhibitors of phenylethanolamine N-methyltransferase that display remarkable potency and selectivity.
    Grunewald GL; Romero FA; Criscione KR
    J Med Chem; 2005 Jan; 48(1):134-40. PubMed ID: 15634007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines.
    Grunewald GL; Romero FA; Seim MR; Criscione KR; Deupree JD; Spackman CC; Bylund DB
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1143-7. PubMed ID: 15686930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental characteristics of phenylethanolamine and octopamine in the rat brain.
    Saavedra JM; Coyle JT; Axelrod J
    J Neurochem; 1974 Sep; 23(3):511-5. PubMed ID: 4153859
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
    J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of synthesis and degradation of rat adrenal phenylethanolamine N-methyltransferase. IV. Synergistic stabilization of the enzyme against thermal and tryptic degradation by S-adenosylmethionine and biogenic amine substrates.
    Masover SJ; Berenbeim DM; Ciaranello RD
    Mol Pharmacol; 1979 Sep; 16(2):491-503. PubMed ID: 514255
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific photoactivated covalent binding of S-adenosylmethionine to phenylethanolamine-N-methyl transferase.
    Yu PH
    Biochim Biophys Acta; 1983 Feb; 742(3):517-24. PubMed ID: 6838886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catecholamine sulfates: end products or metabolic intermediates?
    Demassieux S; Bordeleau L; Gravel D; Carrière S
    Life Sci; 1987 Jan; 40(2):183-91. PubMed ID: 3796219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    Biochem Pharmacol; 1983 Jan; 32(2):215-20. PubMed ID: 6870951
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative structure-activity relationship studies of non-aromatic analogues of ethanolamine as inhibitors of phenylethanolamine N-methyltransferase.
    Singh P
    Arzneimittelforschung; 1985; 35(1):21-3. PubMed ID: 4039148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential inhibitor of S-adenosylmethionine-dependent methyltransferases. 2. Modification of the base portion of S-adenosylhomocysteine.
    Borchardt RT; Huber JA; Wu YS
    J Med Chem; 1974 Aug; 17(8):868-73. PubMed ID: 4845380
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine.
    Borchardt RT; Wu YS
    J Med Chem; 1974 Aug; 17(8):862-8. PubMed ID: 4845379
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
    Liang NY; Tessel RE; Grunewald GL; Borchardt RT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of phenylethanolamine-N-methyltransferase activity by high-performance liquid chromatography with on-line radiochemical detection.
    Nissinen E
    J Chromatogr; 1986 Dec; 371():37-42. PubMed ID: 3558555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically controlled alterations in the rate of degradation of phenylethanolamine N-methyltransferase.
    Ciaranello RD; Axelrod J
    J Biol Chem; 1973 Aug; 248(16):5616-23. PubMed ID: 4723903
    [No Abstract]   [Full Text] [Related]  

  • 35. Catecholamine binding by adrenal medullary protein can interfere with a sensitive radioenzymatic assay for norepinephrine.
    Studelska DR; Campbell NR; Brimijoin WS
    Life Sci; 1985 Mar; 36(9):881-7. PubMed ID: 3974415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probes of the active site of norepinephrine N-methyltransferase: effect of hydrophobic and hydrophilic interactions on side-chain binding of amphetamine and alpha-methylbenzylamine.
    Grunewald GL; Monn JA; Rafferty MF; Borchardt RT; Krass P
    J Med Chem; 1982 Oct; 25(10):1248-50. PubMed ID: 7143366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylethanolamine N-methyltransferase: notes on its purification from bovine adrenal medulla and separation from protein carboxymethyltransferase.
    Hurst JH; Guchhait RB; Billingsley ML; Stolk JM; Lovenberg W
    Biochem Biophys Res Commun; 1983 May; 112(3):1061-8. PubMed ID: 6847678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase.
    Grunewald GL; Ye Q; Kieffer L; Monn JA
    J Med Chem; 1988 Jan; 31(1):169-71. PubMed ID: 3336016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of N-and O-methyltransferases.
    Axelrod J; Vesell ES
    Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.
    Gearhart DA; Neafsey EJ; Collins MA
    Neurochem Int; 2002 Jun; 40(7):611-20. PubMed ID: 11900856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.